Shares of Onconova Therapeutics Inc. (NASDAQ:ONTX) traded up 7.4% during trading on Thursday . The stock traded as high as $4.12 and last traded at $4.07, with a volume of 1,057,410 shares traded. The stock had previously closed at $3.79.

Separately, Maxim Group reaffirmed a “buy” rating and set a $6.00 price objective on shares of Onconova Therapeutics in a research report on Friday. One research analyst has rated the stock with a hold rating and four have issued a buy rating to the stock. The company presently has an average rating of “Buy” and an average price target of $24.74.

The firm’s market capitalization is $10.30 million. The stock’s 50 day moving average is $4.10 and its 200-day moving average is $4.76.

Onconova Therapeutics (NASDAQ:ONTX) last announced its quarterly earnings data on Monday, August 15th. The biopharmaceutical company reported ($1.96) earnings per share for the quarter. The business earned $2.25 million during the quarter. On average, analysts forecast that Onconova Therapeutics Inc. will post ($7.40) earnings per share for the current year.

Onconova Therapeutics, Inc is a clinical-stage biopharmaceutical company. The Company operates through the identification and development of oncology therapeutics segment. It is focused on discovering and developing small molecule drug candidates to treat cancer. The Company has created a targeted anti-cancer agents designed to work against specific cellular pathways that are important to cancer cells.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.